1-BUTYL-3-(4-CHLORO-PHENYL)-UREA
![]() |
- $29.8 - $904
- Product name: 1-BUTYL-3-(4-CHLORO-PHENYL)-UREA
- CAS: 6333-41-1
- MF: C11H15ClN2O
- MW: 226.7
- EINECS:
- MDL Number:MFCD00018554
- Synonyms:1-BUTYL-3-(4-CHLORO-PHENYL)-UREA;Urea, N-butyl-N'-(4-chlorophenyl)-
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Sigma-Aldrich
Package
- 5MG
- 25mg
- 250mg
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0115752
- Product description1-BUTYL-3-(4-CHLORO-PHENYL)UREA 95.00%
- Packaging5MG
- Price$499.07
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12049769
- Product description1-Butyl-3-(4-chlorophenyl)urea 95+%
- Packaging5g
- Price$904
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS591416
- Product description1-BUTYL-3-(4-CHLOROPHENYL)UREA Aldrich
- Packaging250mg
- Price$29.8
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberS279692
- Product description1-BUTYL-3-(4-CHLORO-PHENYL)-UREA Aldrich
- Packaging25mg
- Price$29.8
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | HCH0115752 | 1-BUTYL-3-(4-CHLORO-PHENYL)UREA 95.00% | 5MG | $499.07 | 2021-12-16 | Buy |
Crysdot | CD12049769 | 1-Butyl-3-(4-chlorophenyl)urea 95+% | 5g | $904 | 2021-12-16 | Buy |
Sigma-Aldrich | S591416 | 1-BUTYL-3-(4-CHLOROPHENYL)UREA Aldrich | 250mg | $29.8 | 2024-03-01 | Buy |
Sigma-Aldrich | S279692 | 1-BUTYL-3-(4-CHLORO-PHENYL)-UREA Aldrich | 25mg | $29.8 | 2024-03-01 | Buy |
Properties
Melting point :171-172 °C
Boiling point :313.8±34.0 °C(Predicted)
Density :1.175±0.06 g/cm3(Predicted)
pka :14.02±0.46(Predicted)
Boiling point :313.8±34.0 °C(Predicted)
Density :1.175±0.06 g/cm3(Predicted)
pka :14.02±0.46(Predicted)
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||
Hazard statements: |
|
||||||||||||||
Precautionary statements: |
|